Dipeptidyl peptidase-4 inhibitor (sitagliptin) improves insulin sensitivity and atherosclerosis-related biomarkers in patients with type 2 diabetes

被引：0
|
作者：
Yamane, T. [1 ]
Suzuki, Y. [1 ]
Iwai, R. [2 ]
Sakuma, Y. [2 ]
Yoshida, S. [1 ]
Hashimoto, N. [3 ]
机构：
[1] Asahi Gen Hosp, Chiba, Japan
[2] Asahi Gen Hosp, Clin Lab, Chiba, Japan
[3] Tokyo Womens Med Univ, Chiba, Japan
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
785
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [31] Twelve-week efficacy and tolerability of sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, in Japanese patients with type 2 diabetes
    Nonaka, K.
    Kakikawa, T.
    Sato, A.
    Okuyama, K.
    Fujimoto, G.
    Hayashi, N.
    Suzuki, H.
    Hirayama, Y.
    Stein, P. P.
    DIABETOLOGIA, 2006, 49 : 25 - 26
  • [32] Dipeptidyl Peptidase-4 Inhibitor Use and Risk of Acute Pancreatitis in Patients with Type 2 Diabetes
    Seong, J.
    Choi, N.
    Kim, J.
    Lee, J.
    Kim, Y.
    Park, B.
    DRUG SAFETY, 2013, 36 (09) : 856 - 856
  • [33] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Deacon, Carolyn F.
    Holst, Jens J.
    ADVANCES IN THERAPY, 2009, 26 (05) : 488 - 499
  • [34] Linagliptin: The Newest Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Aletti, Rachael
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2012, 20 (01) : 45 - 51
  • [35] Comparative effects of a dipeptidyl peptidase-4 inhibitor and of NPH insulin on peripheral nerve conduction of patients with type 2 diabetes
    Giordana Maluf da Silva
    Carlos Otto Heise
    Maria Teresa Hirata
    Alberto Andrade de Mello
    Katia Camarano Nogueira
    Rosa Ferreira dos Santos
    Maysa Vieira de Sousa
    Diabetology & Metabolic Syndrome, 7 (Suppl 1):
  • [36] Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Neumiller, Joshua J.
    Campbell, R. Keith
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (18) : 1515 - 1525
  • [37] Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus
    Forst, Thomas
    Pfuetzner, Andreas
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (01) : 21 - 35
  • [38] Alogliptin: A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes Mellitus
    Jarvis, Courtney I.
    Cabrera, Adriana
    Charron, Derek
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1532 - 1539
  • [39] Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Carolyn F. Deacon
    Jens J. Holst
    Advances in Therapy, 2009, 26 : 488 - 499
  • [40] Dutogliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Johnson, Kathryn M. S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (04) : 455 - 463
12345